Mark Quick | Partner, Flerie

Mark joined Flerie in 2022 as a Partner having previously worked at Recipharm where he was Head of Corporate Development leading the M&A activities and help to grow the company into a top five pharmaceutical CDMO. He was also a member of the Executive Committee. Prior to that he held positions in ICI, Medeva, Celltech and UCB in various business development and supply chain roles. At Flerie, he is responsible for the Commercial Growth portfolio and is a board member of several of the portfolio companies both in drug development and commercial growth. He has a first degree in Industrial Studies from Nottingham Trent University and an MBA from the Open Business School.